ARTICLE | Company News
Ambrilia, Covidien Ltd. deal
May 19, 2008 7:00 AM UTC
Ambrilia Biopharma Inc. (TSX:AMB), Verdun, Quebec Covidien Ltd. (NYSE:COV), Hamilton, Bermuda Business: Endocrine The companies ended a 2003 deal, returning U.S. rights to market prolonged-release oc...